# Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

> **NCT00290641** · NA · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 68 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** graft-versus-tumor induction therapy
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00290641
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290641, "Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00290641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*